Artesunate attenuates ACLT-induced osteoarthritis by suppressing osteoclastogenesis and aberrant angiogenesis - 15/12/17
pages | 7 |
Iconographies | 6 |
Vidéos | 0 |
Autres | 0 |
Abstract |
Artesunate (ART) is a semi-synthetic derivative of artemisinin and used preferentially in treatment of malaria in China. ART has strong anti-inflammatory, anti-tumor, and anti-angiogenic properties. Although the pharmacological effect of ART in osteoarthritis (OA) is unknown, evidence suggests that ART might regulate osteoclastogenesis through NF-κB signaling. In this study we explored the therapeutic effect of ART in an anterior cruciate ligament transection (ACLT)-induced OA model. We found that ART effectively relieved ACLT-induced osteoarthritis, as demonstrated by the improvement expression of pathological genes. We further demonstrated that ART markedly reduced OA-associated osteoclastogenesis and angiogenesis. In addition, ART also regulated inflammatory response and inhibited the activation of Janus Kinase/Signal Transducers and Activators of Transcription (JAK/STAT) signaling in ACLT rats. Taken together our study has identified a novel function of ART and provided a molecular basis for ART potential applications in the treatment of OA and other joint disorders.
Le texte complet de cet article est disponible en PDF.Abbreviations : OA, ACLT, JAK/STAT, NSAIDs, CTX-II, PEG2, IL, MMP-9, VEGF, HGF, Ang-1, IGF-1, TGF-β
Keywords : Artesunate, Osteoarthritis, Osteoclast, Angiogenesis, JAK/STAT
Plan
Vol 96
P. 410-416 - décembre 2017 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?